Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
TATA Health International Holdings (HKSE:01255) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
TATA Health International Holdings's EV-to-EBIT for today is
TATA Health International Holdings's current Enterprise Value is HK$579.30 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. TATA Health International Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was HK$16.79 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
TATA Health International Holdings's EV-to-EBITDA for today is:
TATA Health International Holdings's current Enterprise Value is HK$579.30 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. TATA Health International Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was HK$16.79 Mil.
TATA Health International Holdings's current Enterprise Value is HK$579.30 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. TATA Health International Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was HK$99.80 Mil.
TATA Health International Holdings's current Enterprise Value is HK$579.30 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. TATA Health International Holdings's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-16.99 Mil.
TATA Health International Holdings's current Enterprise Value is HK$579.30 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. TATA Health International Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-16.99 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TATA Health International Holdings Enterprise Value Related Terms
TATA Health International Holdings Enterprise Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TATA Health International Holdings Enterprise Value Chart
HKSE:01255 vs NKE, DECK, ONON: Enterprise Value Comparison
For the Footwear & Accessories subindustry, TATA Health International Holdings's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TATA Health International Holdings Enterprise Value vs Manufacturing - Apparel & Accessories Industry
For the Manufacturing - Apparel & Accessories industry and Consumer Cyclical sector, TATA Health International Holdings's Enterprise Value distribution charts can be found below:
* The bar in red indicates where TATA Health International Holdings's Enterprise Value falls into.
TATA Health International Holdings Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of HK$579.30 Mil mean?
TATA Health International Holdings (HKSE:01255) has a Enterprise Value of HK$579.30 Mil as of Jul. 30, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on TATA Health International Holdings and its competitors.
Is TATA Health International Holdings' Enterprise Value too high?
TATA Health International Holdings' current Enterprise Value is HK$579.30 Mil. Overall, TATA Health International Holdings has a GF Score™ of 22/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does TATA Health International Holdings' Enterprise Value compare to NKE and DECK?
TATA Health International Holdings' Enterprise Value of HK$579.30 Mil can be compared against companies in the Manufacturing - Apparel & Accessories industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Manufacturing - Apparel & Accessories company?
A good Enterprise Value depends on the Manufacturing - Apparel & Accessories industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on TATA Health International Holdings and its competitors. TATA Health International Holdings's current Enterprise Value is HK$579.30 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TATA Health International Holdings stock overvalued right now?
Based on GuruFocus' analysis, TATA Health International Holdings (HKSE:01255) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.22, compared to a current price of HK$2.18 — trading 890.9% above its estimated fair value. The current Enterprise Value is HK$579.30 Mil. TATA Health International Holdings' overall GF Score™ is 22/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For TATA Health International Holdings (HKSE:01255), the current Enterprise Value is HK$579.30 Mil as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TATA Health International Holdings (HKSE:01255) Overvalued in 2026?
Based on GuruFocus' analysis, TATA Health International Holdings stock appears to be overvalued.
The current stock price of HK$2.18 is trading 890.9% above its estimated GF Value™ of HK$0.22.
GuruFocus considers TATA Health International Holdings to be Significantly Overvalued.
Key valuation signals for HKSE:01255:
Enterprise Value: HK$579.30 Mil
GF Value™: HK$0.22 vs. price of HK$2.18 (890.9% above fair value)
No single metric tells the full story. See the HKSE:01255 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TATA Health International Holdings Business Description
TATA Health International Holdings Ltd is an investment holding company. Through its subsidiaries, the company operates in four segments: Trading of footwear products, Trading of healthcare products, Financial services, and Online medical services. The majority of its revenue comes from the Trading of footwear products. Geographically, the Group generates maximum revenue from Hong Kong, and the rest from Macau.
22GF Score
Get the complete analysis for HKSE:01255
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01255 has been successfully added to your 
